Yoshihiro Suzuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yoshihiro Suzuki has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Chisei Ra
Division of Molecular Cell Immunology and Allergology, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo, Japan
14 shared publicationsToshio Inoue
Division of Molecular Cell Immunology and Allergology, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo, Japan
12 shared publicationsTetsuro Yoshimaru
Nihon University
10 shared publicationsMiki Suzuki-Karasaki
Department of Dermatology, Nihon University Surugadai Hospital, Tokyo, Japan
3 shared publicationsTakashi Matsui
Division of Molecular Cell Immunology and Allergology, Nihon University Graduate School of Medical Sciences , Tokyo
3 shared publicationsKazufumi Shimizua
2 shared publications
Latest Publications
- 28 February 2013
- Published by Elsevier in Journal of Dermatological Science
- Vol. 69 (2) , e91
Diallyl trisulfide potentiates pro–apoptotic endoplasmic reticulum response in TRAIL–treated human melanoma cells
- 28 February 2013
- Published by Elsevier in Journal of Dermatological Science
- Vol. 69 (2) , e91
Diallyl trisulfide potentiates pro–apoptotic endoplasmic reticulum response in TRAIL–treated human melanoma cells
- Open Access
- 19 May 2010
- Published by MDPI AG in Pharmaceuticals
- Vol. 3 (5) , 1594-1613
NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates
Aspirin (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug (NSAID) that has long been used as an anti-pyretic and analgesic drug. Recently, much attention has been paid to the chemopreventive and apoptosis-inducing effects of NSAIDs in cancer cells. These effects have been thought to be primarily attributed to the inhibition of cyclooxygenase activity and prostaglandin synthesis. However, recent studies have demonstrated unequivocally that certain NSAIDs, including aspirin and its metabolite salicylic acid, exert their anti-inflammatory and chemopreventive effects independently of cyclooxygenase activity and prostaglandin synthesis inhibition. It is becoming increasingly evident that two potential common targets of NSAIDs are mitochondria and the Ca2+ signaling pathway. In this review, we provide an overview of the current knowledge regarding the roles of mitochondria and Ca2+ in the apoptosis-inducing effects as well as some side effects of aspirin, salicylates and other NSAIDs, and introducing the emerging role of L-type Ca2+ channels, a new Ca2+ entry pathway in non-excitable cells that is up-regulated in human cancer cells.
- 19 May 2010
- Published by MDPI AG in Pharmaceuticals
- Vol. 3 (5) , 1594-1613
Open AccessNSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates
Aspirin (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug (NSAID) that has long been used as an anti-pyretic and analgesic drug. Recently, much attention has been paid to the chemopreventive and apoptosis-inducing effects of NSAIDs in cancer cells. These effects have been thought to be primarily attributed to the inhibition of cyclooxygenase activity and prostaglandin synthesis. However, recent studies have demonstrated unequivocally that certain NSAIDs, including aspirin and its metabolite salicylic acid, exert their anti-inflammatory and chemopreventive effects independently of cyclooxygenase activity and prostaglandin synthesis inhibition. It is becoming increasingly evident that two potential common targets of NSAIDs are mitochondria and the Ca2+ signaling pathway. In this review, we provide an overview of the current knowledge regarding the roles of mitochondria and Ca2+ in the apoptosis-inducing effects as well as some side effects of aspirin, salicylates and other NSAIDs, and introducing the emerging role of L-type Ca2+ channels, a new Ca2+ entry pathway in non-excitable cells that is up-regulated in human cancer cells.
- 1 March 2010
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1803 (3) , 372-385
Endothelial nitric oxide synthase is essential for nitric oxide generation, L-type Ca2+ channel activation and survival in RBL-2H3 mast cells
- 1 March 2010
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1803 (3) , 372-385
Endothelial nitric oxide synthase is essential for nitric oxide generation, L-type Ca2+ channel activation and survival in RBL-2H3 mast cells
- 1 January 2010
- Published by Elsevier in Molecular Immunology
- Vol. 47 (4) , 640-648
L-type Ca2+ channels: A new player in the regulation of Ca2+ signaling, cell activation and cell survival in immune cells
- 1 January 2010
- Published by Elsevier in Molecular Immunology
- Vol. 47 (4) , 640-648
L-type Ca2+ channels: A new player in the regulation of Ca2+ signaling, cell activation and cell survival in immune cells
- 1 July 2009
- Published by Elsevier in Molecular Immunology
- Vol. 46 (11-12) , 2200-2209
Discrete generations of intracellular hydrogen peroxide and superoxide in antigen-stimulated mast cells: Reciprocal regulation of store-operated Ca2+ channel activity
- 1 July 2009
- Published by Elsevier in Molecular Immunology
- Vol. 46 (11-12) , 2200-2209
Discrete generations of intracellular hydrogen peroxide and superoxide in antigen-stimulated mast cells: Reciprocal regulation of store-operated Ca2+ channel activity
- 1 July 2009
- Published by Elsevier in Molecular Immunology
- Vol. 46 (11-12) , 2370-2380
Cav1.2 L-type Ca2+ channel protects mast cells against activation-induced cell death by preventing mitochondrial integrity disruption
- 1 July 2009
- Published by Elsevier in Molecular Immunology
- Vol. 46 (11-12) , 2370-2380
Cav1.2 L-type Ca2+ channel protects mast cells against activation-induced cell death by preventing mitochondrial integrity disruption
- Open Access
- 28 April 2009
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 86 (1) , 167-179
Ca2+-dependent mast cell death induced by Ag (I) via cardiolipin oxidation and ATP depletion
Ag (I) induction leads to a unique necrotic death pathway in which Ca2+-dependent cardiolipin oxidation and ATP depletion play critical roles. In genetically susceptible humans and/or experimental animals, ions of heavy metals, Hg (II), Au (III), and Ag (I) have been shown to strongly induce autoimmunity, in which mast cells have been implicated to play a role. Here, we demonstrate that Ag (I) application results in mast cell death through a unique Ca2+- and mitochondria-dependent pathway. As cellular susceptibilities to Ag (I) cytotoxicity varied considerably, we analyzed the cell death pathway in the low and high responding cells. In the low responding cells, long application (e.g., 20 h) of Ag (I) at concentrations (≥30 μM) induced cell death, which was accompanied by mitochondrial membrane depolarization, cyt c release, and caspase-3/7 activation but was not prevented by selective inhibitors of caspase-3/7 and the mitochondrial permeability transition. The cell death was preceded by elevations in the cytoplasmic and mitochondrial Ca2+ levels, and Ca2+ responses and cell death were prevented by thiol reagents, including DTT, N-acetylcysteine, and reduced glutathione monoethyl ester. In the high responding cells, Ag (I) evoked considerable cell death by necrosis within 1 h, without inducing caspase activation, and this cell death was reduced significantly by depleting extracellular but not intracellular Ca2+. Moreover, Ag (I) strongly induced Ca2+-dependent CL oxidation and intracellular ATP depletion, both of which were blocked by thiol reagents. These results suggest that Ag (I) activates thiol-dependent Ca2+ channels, thereby promoting Ca2+-dependent CL oxidation, cyt c release, and ATP depletion. This necrotic cell death may play roles in Ag-induced inflammation and autoimmune disorders.
- 28 April 2009
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 86 (1) , 167-179
Open AccessCa2+-dependent mast cell death induced by Ag (I) via cardiolipin oxidation and ATP depletion
Ag (I) induction leads to a unique necrotic death pathway in which Ca2+-dependent cardiolipin oxidation and ATP depletion play critical roles. In genetically susceptible humans and/or experimental animals, ions of heavy metals, Hg (II), Au (III), and Ag (I) have been shown to strongly induce autoimmunity, in which mast cells have been implicated to play a role. Here, we demonstrate that Ag (I) application results in mast cell death through a unique Ca2+- and mitochondria-dependent pathway. As cellular susceptibilities to Ag (I) cytotoxicity varied considerably, we analyzed the cell death pathway in the low and high responding cells. In the low responding cells, long application (e.g., 20 h) of Ag (I) at concentrations (≥30 μM) induced cell death, which was accompanied by mitochondrial membrane depolarization, cyt c release, and caspase-3/7 activation but was not prevented by selective inhibitors of caspase-3/7 and the mitochondrial permeability transition. The cell death was preceded by elevations in the cytoplasmic and mitochondrial Ca2+ levels, and Ca2+ responses and cell death were prevented by thiol reagents, including DTT, N-acetylcysteine, and reduced glutathione monoethyl ester. In the high responding cells, Ag (I) evoked considerable cell death by necrosis within 1 h, without inducing caspase activation, and this cell death was reduced significantly by depleting extracellular but not intracellular Ca2+. Moreover, Ag (I) strongly induced Ca2+-dependent CL oxidation and intracellular ATP depletion, both of which were blocked by thiol reagents. These results suggest that Ag (I) activates thiol-dependent Ca2+ channels, thereby promoting Ca2+-dependent CL oxidation, cyt c release, and ATP depletion. This necrotic cell death may play roles in Ag-induced inflammation and autoimmune disorders.
- 1 April 2009
- Published by Elsevier in Molecular Immunology
- Vol. 46 (7) , 1267-1277
L-type Ca2+ channels in mast cells: Activation by membrane depolarization and distinct roles in regulating mediator release from store-operated Ca2+ channels
- 1 April 2009
- Published by Elsevier in Molecular Immunology
- Vol. 46 (7) , 1267-1277
L-type Ca2+ channels in mast cells: Activation by membrane depolarization and distinct roles in regulating mediator release from store-operated Ca2+ channels
- Open Access
- 1 January 2009
- Published by Japanese Pharmacological Society in Journal of Pharmacological Sciences
- Vol. 110 (3) , 237-244
Analysis of the Mechanism for the Development of Allergic Skin Inflammation and the Application for Its Treatment: Aspirin Modulation of IgE-Dependent Mast Cell Activation: Role of Aspirin-Induced Exacerbation of Immediate Allergy
Aspirin (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute allergies and causes adverse immunological reactions collectively referred to as aspirin intolerance, a disorder that induces urticaria, asthma, and anaphylaxis in response to oral administration of the drug. Aspirin also potentiates some acute allergies such as food-dependent exercise-induced anaphylaxis (FDEIA), a food allergy induced by physical exercise. The anti-inflammatory actions as well as the adverse immunological effects have been thought to be primarily due to inhibition of cyclooxygenase activity. However, a growing body of evidence suggests that mechanisms unrelated to inhibition of prostaglandin synthesis are involved. One key feature of aspirin intolerance is the overproductions of cysteinyl leukotrienes (LTs), in which mast cells have been implicated to play a role. In this review, we provide an overview of our current knowledge about the regulatory mechanisms of LTC4 secretion in mast cells and its modulation by aspirin, with a special emphasis on the role of Ca2+ signals. We also introduced our recent findings that mast cells express dihydropyridine-sensitive L-type Ca2+ channels (LTCCs) and that Ca2+ channels of this kind mediate aspirin modulation of LTC4 secretion in mast cells.
- 1 January 2009
- Published by Japanese Pharmacological Society in Journal of Pharmacological Sciences
- Vol. 110 (3) , 237-244
Open AccessAnalysis of the Mechanism for the Development of Allergic Skin Inflammation and the Application for Its Treatment: Aspirin Modulation of IgE-Dependent Mast Cell Activation: Role of Aspirin-Induced Exacerbation of Immediate Allergy
Aspirin (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute allergies and causes adverse immunological reactions collectively referred to as aspirin intolerance, a disorder that induces urticaria, asthma, and anaphylaxis in response to oral administration of the drug. Aspirin also potentiates some acute allergies such as food-dependent exercise-induced anaphylaxis (FDEIA), a food allergy induced by physical exercise. The anti-inflammatory actions as well as the adverse immunological effects have been thought to be primarily due to inhibition of cyclooxygenase activity. However, a growing body of evidence suggests that mechanisms unrelated to inhibition of prostaglandin synthesis are involved. One key feature of aspirin intolerance is the overproductions of cysteinyl leukotrienes (LTs), in which mast cells have been implicated to play a role. In this review, we provide an overview of our current knowledge about the regulatory mechanisms of LTC4 secretion in mast cells and its modulation by aspirin, with a special emphasis on the role of Ca2+ signals. We also introduced our recent findings that mast cells express dihydropyridine-sensitive L-type Ca2+ channels (LTCCs) and that Ca2+ channels of this kind mediate aspirin modulation of LTC4 secretion in mast cells.
- 1 May 2008
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1783 (5) , 924-934
Galectin-3 but not galectin-1 induces mast cell death by oxidative stress and mitochondrial permeability transition
- 1 May 2008
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1783 (5) , 924-934
Galectin-3 but not galectin-1 induces mast cell death by oxidative stress and mitochondrial permeability transition